| 非小细胞肺癌治疗新进展 |
| |
| 引用本文： | 张群,陈龙邦. 非小细胞肺癌治疗新进展[J]. 医学研究生学报, 2001, 14(4): 354-355 |
| |
| 作者姓名： | 张群 陈龙邦 |
| |
| 作者单位： | 南京军区南京总医院肿瘤科 |
| |
| 摘 要： | 非小细胞肺癌(NSCLC)在世界各地的发病率逐年上升,由于患者就诊时80%～90%的病例已有转移,因此化疗是不可缺少的治疗手段.随着一些新药的问世,明显提高了NSCLC的疗效.本文综述了各期非小细胞肺癌的治疗新进展.
|
| 关 键 词： | 非小细胞肺癌 化学治疗 |
| 文章编号： | 1008-8199(2001)04-0354-02 |
| 修稿时间： | 2000-11-11 |
The therapy of new agents in non-small cell lung cancer:a review |
| |
| ZHANG Qun reviewing,CHEN Long bang checking. The therapy of new agents in non-small cell lung cancer:a review[J]. Bulletin of Medical Postgraduate, 2001, 14(4): 354-355 |
| |
| Authors: | ZHANG Qun reviewing CHEN Long bang checking |
| |
| Abstract: | Non small cell lung cancer(NSCLC) remains a worldwide problem. Chemotherapy was necessary for patients with advanced NSCLC,because the vast majority of patients develop metastasis at the time of diagonosis.Recently,some new agents were shown to produce higher response rates and longer survival.This paper describes therapy of the new agents in patients with NSCLC. |
| |
| Keywords: | Non small cell lung cancer Chemotherapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
